Tag: BMO

May 20, 2018

Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
May 3, 2018

Tesla to Reduce Cobalt Use in EV Batteries to “Almost Nothing”

The US-based carmaker is set to further reduce the amount of cobalt used in its batteries, increasing investors' concerns about...
May 3, 2018

Stats Canada Says National Real GDP Up 3.3 Percent

New data shows that with provinces like Alberta and BC leading the pack, 2017 brought Canada's strongest increase in real...
May 1, 2018

Critical Elements Announces Closing of $7 Million Bought Deal Financing of Units

Critical Elements (TSXV:CRE, OTCQX:CRECF, FWB:F12) (“Critical Elements” or the “Company”) is pleased to announce that it has closed its private...
April 30, 2018

Oils and New Production Boost Cronos’ Fourth Quarter

As part of its quarterly update to shareholders, Cronos Group reported growth in sales thanks to cannabis oils and increased...
April 29, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 27, 2018

Cannabis Weekly Round-Up: 3 New Cannabis Stocks Set to Launch in Canada

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
April 19, 2018

Hiku Brands and WeedMD to Merge in Transformational Transaction to Create Vertically Integrated Industry Leader

Hiku Brands Company Ltd. (“Hiku”) (CSE:HIKU) and WeedMD Inc. (TSXV:WMD, OTC:WDDMF) (FSE:4WE) (“WeedMD”), are pleased to announce that today they have entered into a definitive agreement (the...
April 18, 2018

Nickel Price Climbs to Three-year High on Russia Sanctions Fears

The price of nickel soared to a three-year high of US$15,275 on the back of fears that another round of...
April 18, 2018

Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock

Aeglea BioTherapeutics (Nasdaq:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic...